CN1398615A - Chinese medicine prepn for treating fatty liver and obesity - Google Patents
Chinese medicine prepn for treating fatty liver and obesity Download PDFInfo
- Publication number
- CN1398615A CN1398615A CN 02125521 CN02125521A CN1398615A CN 1398615 A CN1398615 A CN 1398615A CN 02125521 CN02125521 CN 02125521 CN 02125521 A CN02125521 A CN 02125521A CN 1398615 A CN1398615 A CN 1398615A
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- rhizoma atractylodis
- fatty liver
- obesity
- medicinal liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine preparation for treating fatty liver and obesity is prepared with atractylodes rhizome, white atractylodes rhizome, magnolia bark, bitter organe, orange peel and other seven kinds of Chinese medicinal materials. It is prepared with natural plant material, has obvious curative effect, no stimulation to gastrointestinal tract, and low cost.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of Chinese medicine preparation for the treatment of fatty liver and obesity.
Background technology
Along with deepening continuously of reform and opening-up, people's material life is greatly improved, and the structure content of clothing, food, lodging and transportion--basic necessities of life all changes thereupon, and spectrum of disease is also corresponding and change.So-called affluenza takes place thereupon, and for example the sickness rate of obesity, merging cardiovascular and cerebrovascular disease, hypertension, coronary heart disease, cerebrovascular accident, diabetes, fatty liver etc. significantly rises, and people's health and lives in serious threat.At present, because the good treatment of life, the too much absorption of nutrition and the obese fatty liver disease that causes has become one of unhealthful frequently-occurring disease, commonly encountered diseases, the common method of treatment of obesity has the weight-reducing by dieting method, the weight reduction with drugs method, the weight-reducing by dieting method is generally with the low heat value food meal, or the feed of semistarvation state, loses weight with the description and quantity that limits feed.Owing to limited feed, do not guarantee normal nutritional need, can make weak, the anorexia of people, health is affected, and also can rebound after the fat-reducing.Existing Drug therapy fatty liver person also can limit feed to a certain extent.The active drug of treatment fatty liver is few, and effect is not satisfactory, and Western medicine is chemically made, the more complicated price height of technology, and often take and can stimulation be arranged to stomach.
Content of the present invention
The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of fatty liver and obesity, it has evident in efficacy, does not rebound, and is non-stimulated to gastrointestinal, the advantage that price is low.
The objective of the invention is to realize by following technical scheme.The present invention is a kind of Chinese medicine preparation for the treatment of fatty liver and obesity, it is characterized in that it is made of by weight proportion following component: Rhizoma Atractylodis 3-5 Rhizoma Atractylodis Macrocephalae 3-5 Cortex Magnoliae Officinalis 3-5 Fructus Aurantii 3-5 Pericarpium Citri Reticulatae 3-5 Rhizoma Pinelliae 2-4 Radix Platycodonis 3-5 Semen Sinapis Albae 2-4 Semen Raphani 4-5 Radix Et Rhizoma Rhei 3-5 Rhizoma Alismatis 4-5 Fructus Crataegi 4-5
Its method for production comprises following step preface:
(1) get the raw materials ready, each component got all the ready by prescription,
(2) pulverize, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis pulverized, sieve,
(3) decocting and concentrating, all the other component waters decoct in will filling a prescription, and decoct successively 3 hours, will
Medicinal liquid takes out; Add water again medical material was decocted 2 hours, medicinal liquid is taken out; Adding water again will
Medical material decocted 1 hour, and medicinal liquid is taken out; The medicinal liquid of above-mentioned three decoctions is mixed,
Be condensed into fluid extract;
(4) mix, above-mentioned Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, the pool that adds above-mentioned pulverizing in the fluid extract that be condensed into
Rush down powder, mixing;
(5) drying and crushing is with dry fine powder, the mixing of also being ground into again of each component of mixing;
(6) preparation is made preparation with above-mentioned fine powder.
Theory of Chinese medical science thinks that the origin cause of formation of obese fatty liver disease is mainly nutrition and crosses and contain (though fatty liver also may because chronic alcoholism, diabetic supersession are unusual, hepatitis causes) in the majority.Fatty liver and obesity are common in polyphagia delicious food on ordinary days, and after the people that physical exertion is less, particularly middle age, spleen fortuneization function day by day goes down, if more double eating and drinking without temperance, be disinclined to activity, temper is not transported, then the paddy food can not turn to and precise and tiny gathering form phlegm-damp, and interior work causes the irritability catharsis in body.Jin Dynasty well-known doctor Li Dongyuan calls splenogastric asthenia, obesity with poor appetite, though fertilizer and inability to raise the limbs, this is as the tired drowsy and lazy moving disease of the fat people Chang Yi of clinical findings fat.Many obese patients often tell that diet is controlled and body fertilizer does not still subtract, also above-mentioned just so.The people of obesity merges the fatty liver, and the person is a lot, but the lighter's non-evident sympton is more if liver fat stockpiles, and can feel diseases such as right side of body rib hepatic region distension or pain and abdominal distention is tired.The traditional Chinese medical science is thought insufficiency of the spleen phlegm resistance, irritability imbalance so, then phlegm-damp is from disappearing if spleen can be built transport, irritability also can freely be transferred.The applicant makes this Chinese medicine preparation according to above-mentioned theory of Chinese medical science.In the Chinese medicine preparation of the present invention, adopt spleen invigorating to help fortune wet the stagnant method of removing food stagnancy of reducing phlegm, the employing Rhizoma Pinelliae, Pericarpium Citri Reticulatae, Radix Platycodonis, Semen Sinapis Albae are wet to reduce phlegm; Adopt Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae with spleen invigorating; Cortex Magnoliae Officinalis, Fructus Aurantii, Semen Raphani expand to remove; Rhizoma Alismatis is with dampness removing; Fructus Crataegi, Radix Et Rhizoma Rhei amass to remove; And Rhizoma Alismatis, Fructus Crataegi also have the effect of blood fat reducing.
In sum, the reason that the present invention is directed to the generation of obese fatty liver disease is suited the remedy to the case, and is remarkable through clinical result of use, do not rebound.Also can treat hyperlipidemia.This preparation medicine source is a natural plants, and its technology simpler production price is low, takes gastrointestinal is had no adverse reaction.
Embodiment 1 capsule
The present invention once carried out clinical practice with the sharp capsule for protecting liver of preparation fat eliminating by name, and effect is remarkable.
Prescription: by part by weight preparation Rhizoma Atractylodis 4 Rhizoma Atractylodis Macrocephalaes 4 Cortex Magnoliae Officinalis 4 Fructus Aurantii 4 Pericarpium Citri Reticulataes 4 Rhizoma Pinelliaes 3 Radix Platycodoniss 4 Semen Sinapis Albaes 3 Semen Raphanis 5 Radix Et Rhizoma Rhei 4 Rhizoma Alismatis 5 Fructus Crataegis 5 of following component
Method for production comprises following step preface:
(1) gets the raw materials ready, each component medical material is selected, after the roguing, cleaning, drying, pressed formula proportion
Each component is got all the ready,
(2) pulverize, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis pulverized, cross 100 mesh sieves,
(3) decocting and concentrating, all the other component waters decoct in will filling a prescription, decoct 3 hours successively after,
Medicinal liquid is taken out; Decoct with water 2 hours again, medicinal liquid is taken out; Decoct with water 1 again
Hour, medicinal liquid is taken out; Decoct the medicinal liquid that produces with above-mentioned three times and mix, be condensed into
Fluid extract;
(4) mix, with above-mentioned be condensed into the Rhizoma Atractylodis that add above-mentioned pulverizing in the fluid extract, the Rhizoma Atractylodis Macrocephalae,
Rhizoma Alismatis powder, mixing;
(5) drying and crushing with each component drying of above-mentioned mixing, and is ground into fine powder, mixing again;
(6) preparation incapsulates into capsule preparations with above-mentioned fine powder.
Embodiment 2 tablets
Prescription: with the prescription of embodiment 1.
Method for production:
(1), (2), (3) (4), (5) are all with the corresponding step preface of embodiment 1.
(6) preparation with above-mentioned fine powder and excipient fusion, is pressed into tablet with tablet machine.
The present invention once with the sharp capsule for protecting liver of fat eliminating be the clinical practice of preparation name in treatment fatty liver, obesity, its effect is remarkable, has spleen invigorating and helps fortune, the wet removing food stagnancy that the reduces phlegm effect that stagnates.Clinical practice improves right distending pain over the hypochondrium, abdominal distention, weak symptom significantly in treatment fatty liver and obesity 368 examples, the 2-4 kilogram of losing weight per course of treatment, and 1/3rd patient through the color ultrasound check, recovers normal after the treatment of 1-3 the course of treatment mostly.Most patient symptoms disappear, and weight loss meets the clinical cure condition.In 368 patients, nearly 1/5th people took existing lipid lowerers DB GANTAI PIAN, liver-protecting tablet and other Chinese patent medicine 2 in advance and did not improve symptom by 3 months or 5 to 8 months.It is remarkable to take the sharp capsule for protecting liver effect of fat eliminating of the present invention, as following table:
The sharp capsule for protecting liver curative effect of fat eliminating statistical table
The efficacy assessment standard of foundation (by slight person 1-2 course of treatment, moderate person 2-3 course of treatment, the severe person 3-4 effect of the course of treatment, be 2 months per course of treatment):
Cure: cardinal symptom disappears, and hepatomegaly disappears or retraction, and the hepatic region does not have obvious tenderness or percussion pain, and liver function is normal, and ultrasonic echo figure and ultrasonogram are normal, and blood fat is tending towards normal or obviously improves weight loss.
Take a turn for the better: cardinal symptom disappears substantially, and hepatomegaly is recovered to some extent, and ultrasonoscopy is clearly better, and blood fat makes moderate progress, and body weight descends to some extent.
Invalid: symptom, sign, chemical examination, ultrasonoscopy and body weight do not have the changer.
Preparation of the present invention has the obvious patient's of improvement the weak effect of right distending pain over the hypochondrium, abdominal distention, and has the effect that Weight-reducing and lipid-lowering improves liver function through clinical practice.By medicine of the present invention as can be seen in the table, curing number in 368 examples is 266 examples, and its cure rate is 72%, and good revolution is 94 examples, accounts for 26%, and invalid is 8 examples, accounts for 2%, and total effective rate is 98%.Have no adverse reaction in taking.
Claims (2)
1, a kind of Chinese medicine preparation for the treatment of fatty liver and obesity is characterized in that it is made of by weight proportion following component: Rhizoma Atractylodis 3-5 Rhizoma Atractylodis Macrocephalae 3-5 Cortex Magnoliae Officinalis 3-5 Fructus Aurantii 3-5 Pericarpium Citri Reticulatae 3-5 Rhizoma Pinelliae 2-4 Radix Platycodonis 3-5 Semen Sinapis Albae 2-4 Semen Raphani 4-5 Radix Et Rhizoma Rhei 3-5 Rhizoma Alismatis 4-5 Fructus Crataegi 4-5
2, a kind of method for production for the treatment of the Chinese medicine preparation of fatty liver and obesity according to claim 1 is characterized in that comprising following step preface:
(1) get the raw materials ready, each component got all the ready by prescription,
(2) pulverize, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Rhizoma Alismatis pulverized, sieve,
(3) decocting and concentrating, all the other component waters decoct in will filling a prescription, and decoct successively 3 hours, will
Medicinal liquid takes out; Add water again medical material was decocted 2 hours, medicinal liquid is taken out; Adding water again will
Medical material decocted 1 hour, and medicinal liquid is taken out; The medicinal liquid of above-mentioned three decoctions is mixed,
Be condensed into fluid extract;
(4) mix, above-mentioned Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, the pool that adds above-mentioned pulverizing in the fluid extract that be condensed into
Rush down powder, mixing;
(5) drying and crushing is with dry fine powder, the mixing of also being ground into again of each component of mixing;
(6) preparation is made preparation with above-mentioned fine powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021255210A CN1171615C (en) | 2002-07-17 | 2002-07-17 | Chinese medicine prepn for treating fatty liver and obesity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021255210A CN1171615C (en) | 2002-07-17 | 2002-07-17 | Chinese medicine prepn for treating fatty liver and obesity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1398615A true CN1398615A (en) | 2003-02-26 |
| CN1171615C CN1171615C (en) | 2004-10-20 |
Family
ID=4745580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021255210A Expired - Fee Related CN1171615C (en) | 2002-07-17 | 2002-07-17 | Chinese medicine prepn for treating fatty liver and obesity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1171615C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100444868C (en) * | 2004-11-04 | 2008-12-24 | 苗毅韧 | Weight-reducing Chinese medicinal formulation and preparation process thereof |
| CN101417056B (en) * | 2008-12-09 | 2011-01-12 | 赵玉红 | Traditional Chinese medicine decoction for treating obesity |
| CN101401918B (en) * | 2008-11-06 | 2011-06-01 | 韩海林 | Chinese medicinal composition for treating fatty liver |
| CN102698225A (en) * | 2012-05-31 | 2012-10-03 | 李新欣 | Chinese medicine for treating postpartum paroxysmal obesity |
| CN109331104A (en) * | 2018-11-09 | 2019-02-15 | 南宁学院 | A kind of drug and preparation method thereof for treating obesity |
| CN111228422A (en) * | 2020-04-01 | 2020-06-05 | 嘉应学院 | Traditional Chinese medicine composition for reducing intramuscular fat of chicken and application and preparation method thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101417058B (en) * | 2008-12-10 | 2011-04-27 | 逯传玲 | Traditional Chinese medicine combination for treating obesity |
-
2002
- 2002-07-17 CN CNB021255210A patent/CN1171615C/en not_active Expired - Fee Related
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100444868C (en) * | 2004-11-04 | 2008-12-24 | 苗毅韧 | Weight-reducing Chinese medicinal formulation and preparation process thereof |
| CN101401918B (en) * | 2008-11-06 | 2011-06-01 | 韩海林 | Chinese medicinal composition for treating fatty liver |
| CN101417056B (en) * | 2008-12-09 | 2011-01-12 | 赵玉红 | Traditional Chinese medicine decoction for treating obesity |
| CN102698225A (en) * | 2012-05-31 | 2012-10-03 | 李新欣 | Chinese medicine for treating postpartum paroxysmal obesity |
| CN109331104A (en) * | 2018-11-09 | 2019-02-15 | 南宁学院 | A kind of drug and preparation method thereof for treating obesity |
| CN111228422A (en) * | 2020-04-01 | 2020-06-05 | 嘉应学院 | Traditional Chinese medicine composition for reducing intramuscular fat of chicken and application and preparation method thereof |
| CN111228422B (en) * | 2020-04-01 | 2021-09-17 | 嘉应学院 | Traditional Chinese medicine composition for reducing intramuscular fat of chicken and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1171615C (en) | 2004-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1245883C (en) | Slim tea | |
| CN1171615C (en) | Chinese medicine prepn for treating fatty liver and obesity | |
| CN1110924A (en) | Effective drug for gastric disease | |
| CN1823995A (en) | New medicine for treating malignant tumour | |
| CN1066332C (en) | Hypoglycemic compound capsule | |
| CN100334972C (en) | Body building health preparation and its producing method | |
| CN1879783A (en) | A medicine for treating diabetes | |
| CN1109553C (en) | Chinese-medicinal capsule for treating diabetes | |
| CN1611232A (en) | Medicinal composition with main effect of antifatigue, radioresistance and melancholia-resistance and its preparing method | |
| CN1050292C (en) | Anticancer drug and preparing method thereof | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN101953959A (en) | Chinese medicament for treating diabetic gastroparalysis | |
| CN1285367C (en) | Medicinal preparation for treating diabetes and its preparation method | |
| CN1217204A (en) | Medicine for nourishing muscle and recovering physical strength, and preparation method therefor | |
| CN1086129C (en) | Hepatitis restoration pill | |
| CN1850160A (en) | Qidantongmai Tablet, and its preparing process | |
| CN1322536A (en) | Laxative and its preparation | |
| CN103933282A (en) | Traditional Chinese medicine preparation for treating diabetes | |
| CN108542946B (en) | Traditional Chinese medicine prescription with weight-losing function and preparation method thereof | |
| CN1247251C (en) | Hyperlipemia treating medicine | |
| CN101032613B (en) | Hepatic cyst-treating Chinese traditional medicine preparation and its preparation process | |
| CN101036742A (en) | Medicine for treating prostatic disease | |
| CN1148969A (en) | Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing | |
| CN1634541A (en) | Medicine for treating fatigue syndrome and preventing presenility, and preparation method thereof | |
| CN1813876A (en) | Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| DD01 | Delivery of document by public notice |
Addressee: Cui Xingzhong Document name: Notification of Termination of Patent Right |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041020 Termination date: 20180717 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |